Stockscreener 앱 받기
2.27
1.30%
-0.03
Glucotrack Inc 주식(GCTK)의 최신 뉴스
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack Announces $11.5 Million Financing - Finviz
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - kalkinemedia.com
GlucoTrack, Inc. announced that it has received $9.045015 million in funding - marketscreener.com
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
Lōkahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions - Finviz
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - kalkinemedia.com
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack (GCTK) adds Lokahi merger statements and pro forma results - stocktitan.net
Glucotrack (NASDAQ: GCTK) reveals 90% Lokahi stake and going-concern warning - Stock Titan
GlucoTrack Announces 1-for-15 Reverse Stock Split - The Globe and Mail
Glucotrack Sets 1-for-15 Reverse Stock Split to Address Nasdaq Requirement - citybiz
Glucotrack announces 1-for-15 reverse split to reduce shares, CUSIP update, Nasdaq compliance goal - tradingview.com
Glucotrack to implement 1-for-15 reverse stock split Monday By Investing.com - Investing.com Nigeria
Glucotrack to implement 1-for-15 reverse stock split Monday - Investing.com
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 - Yahoo Finance
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Lōkahi Therapeutics Expands ai² Futures Lab Asset Origination Network Through Continued Collaboration with the University of Georgia - Finviz
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - minichart.com.sg
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com Canada
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
3.47%
자본화:
|
볼륨(24시간):